Navigation Links
AHIP Statement on New CBO Report Showing That Senate Legislation Will Cut Medicare Advantage Enrollment by 2.3 Million
Date:7/9/2008

WASHINGTON, July 9 /PRNewswire-USNewswire/ -- The Congressional Budget Office (CBO) estimates that Medicare legislation currently being considered in the U.S. Senate (H.R. 6331) would decrease enrollment in Medicare Advantage by about 2.3 million individuals over the next five years. Karen Ignagni, President and CEO of America's Health Insurance Plans (AHIP) issued the following statement:

"More than two million seniors across the country stand to lose their Medicare Advantage benefits if these cuts become law. This could have devastating impact on seniors who rely on the extra benefits and lower out-of-pocket costs these plans provide. While it is important that Congress address the physician payment issue, they shouldn't take away seniors' health care choices in the process."

The CBO report is available here: http://www.cbo.gov/ftpdocs/95xx/doc9550/hr6331GreggLtr.pdf.

America's Health Insurance Plans - Providing Health Benefits to More Than 200 Million Americans


'/>"/>
SOURCE America's Health Insurance Plans
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. American Legacy Foundation(R) Statement of Support for the Federal Trade Commission Reversal on Tar and Nicotine Yield Statements on Cigarettes
2. The ECNP consensus statement on bipolar depression
3. Blue Cross and Blue Shield Association Statement: Health Care America Now
4. Anthem Blue Cross Statement on Settlement Discussions with the California Department of Managed Health Care
5. Statement Regarding the Filing of Signatures to Put the Human Embryo Stem Cell Issue on the November Statewide Ballot
6. GO3 Statement Regarding Erroneous Coverage in Star Magazine
7. AAHSA Statement: Therapy Caps Ration Care
8. Statement by Christine James-Brown, President and CEO, Child Welfare League of America (CWLA) Re: Moratorium on Medicaid Regulations
9. Test For Life Shares Senator Burr Statement on National HIV Testing Day
10. National Headache Foundation Offers Statement, Experts on Appropriate Use of Medications for Migraine Treatment
11. Pelosi Statement on Strong Bipartisan Vote in the House for Medicare Improvements Act
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Lakes, NJ (PRWEB) , ... December 05, 2016 ... ... recording studio teaming up on new songs with prolific Songwriter-Producer Corey “Chorus” Gibson ... Foxx, Kelly Rowland, Ciara, Brandy…just to name a few.     https://twitter.com/coreychorus , ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... moisture measurements are consistently correct. However, regular performance testing is often neglected ... offers a solution: SmartCal™ . This innovative test substance offers a ...
(Date:12/4/2016)... York, NY (PRWEB) , ... December 03, 2016 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – hosted its first Swirl: A Wine Tasting Event in New York ...
(Date:12/4/2016)... ... 04, 2016 , ... "Pro3rd Displace is a set of ... displacement design elements," said Christina Austin - CEO of Pixel Film Studios. ... of design styles that include both left aligned and right aligned options for ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Lori G. ... Traurig, LLP’s Atlanta office, will speak at the American Conference Institute’s 21st Drug ... Traurig is also a Lead Sponsor of the conference. , Cohen, who chairs the ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- M ichael Moore ... Chairman   Mission Therapeutics, a drug discovery and ... treat cancer, neurodegenerative and other diseases, announces that Dr ... January 1 st 2017. Dr Colin Goddard ... in July 2015. Michael Moore , Mission,s Founder Chairman, ...
(Date:12/4/2016)... 3, 2016 Johnson & Weaver, LLP announces that ... of Zimmer Biomet Holdings, Inc. (NYSE: ZBH ) ... 31, 2016 (the "Class Period"). Zimmer Biomet provides ... orthopaedic reconstructive products, such as knee and hip reconstructive products. ... , , ...
(Date:12/4/2016)... , Dec. 3, 2016  Results from the ... SelG1), an anti-P-selectin antibody, reduced the median annual rate ... to placebo (1.63 vs 2.98, p=0.010) in patients with ... that the data are being featured in the official ... of Hematology (ASH) Annual Meeting and presented during the ...
Breaking Medicine Technology: